1/3/2025NMPA Withdraws Registration for Belladonna Sulfabenzamide Tablets

1/3/2025NMPA Issues Annexes for Pharmaceutical Excipients and Packaging Materi...

1/3/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (90...

1/3/2025CDE Issues the Technical Guidelines for Clinical Pharmacology Research...

1/3/2025HighLightHill Pharma Secures CNY 150M in Series Pre-C Financing

1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...

1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...

1/3/2025Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China

1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing

1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...

1/3/2025Recent Official and Executive Moves

1/2/2025Roche and Innovent Enter Global License Deal for Novel DLL3 ADC 

1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale

12/30/2024TEVIMBRA Approved in the U.S. as First-line Treatment of G/GEJ in Com...

12/30/2024 India Deepens Ties with Chinese Biotech: Cipla and Mankind Lead the W...

12/30/2024Solasia Struggles to Finalize China Deal, Lowers 2024 Financial Guidan...

12/30/2024NMPA Announces Package Insert Revision of Potassium Bismuth Citrate Gr...

12/30/20242025 New Drug Outlook: Increasing Global Launch Share of Chinese Innov...

12/30/2024NMPA Approves Alpha/AZ's Zorifer for NSCLC

12/30/2024Duality Announces B7H4 ADC Milestone and License Exercise by BeiGene

12/30/2024CARsgen Reports Positive Topline Results from China GC/GEJ Pivotal Pha...

12/30/2024Reforgene Secures Major Financing to Advance Gene-Editing Therapies

12/30/2024TJ Bio Submits BLA for Genexine's Long-Acting Pediatric Growth Hormone...

12/30/20242025 Forecast: What Can AstraZeneca's China Probes Teach Other Biophar...

12/29/2024IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for AD...

12/29/2024Hong Kong Accepts IPO Application from GenFleet Therapeutics

12/29/2024CSRC Approves Ascentage Pharma's U.S. IPO Filing

12/27/2024Review of China's Hospital Drug Market: Strong Competition Amid Slight...

12/27/2024China's Innovative Drug Approvals in 2024 and Blockbusters Anticipated...

12/27/2024China's Commercial Health Insurance: Growth Trends and Challenges in C...

Page:18/761 Total number of articles:22823: [First][<<] [16] [17] [18] [19] [20] [>>] [End]